ClinicalTrials.gg
Drug

Ningetinib clinical trials

Includes 5 studies of Ningetinib tosylate.

studies test it
5
open now
0
in phase 3
0
first study started
2014

How each study uses ningetinib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

Studies by the year they started

5 studies that test it; most in 2014 (1)

Studies that test ningetinib, by start year
YearStudies
20141
20161
20171
20181
20221

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 2
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 5 · Other 0

Sunshine Lake Pharma Co., Ltd. (5)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses ningetinib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 5

Given beside what is tested · 1 — ningetinib is usual care or a partner of the new treatment

Codes

What other systems call ningetinib · ClinicalTrials.gg INT017619

  • UNII (FDA) PW3Q92Z6A4NINGETINIBOne source FDA
  • NCI Thesaurus C214441NingetinibOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.